Clinical Trial: CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer

U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07322094) titled 'CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer' on Dec. 17, 2025.

Brief Summary: A Phase 1B/2 Study to Investigate the Safety and Efficacy of TORL-1-23 with Chemotherapy Given Before Initial Surgery in Women with Advanced Stage Ovarian Cancer

Study Start Date: Dec. 10, 2025

Study Type: INTERVENTIONAL

Condition: FIGO Stage III and IV Ovarian Cancer Fallopian Tube Cancers Primary Peritoneal Cancer

Intervention: COMBINATION_PRODUCT: TORL-1-23 and paclitaxel

TORL-1-23 and paclitaxel

COMBINATION_PRODUCT: TORL-1-23 an...